Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/17/2014 | US8753622 Seneca valley virus based compositions and methods for treating disease |
06/17/2014 | US8753607 Methods and kits for the differential diagnosis of Alzheimer's disease versus frontotemporal dementia and for the diagnosis of frontotemporal dementia, comprising FAS-L and CK 18 as biomarkers |
06/17/2014 | CA2627907C Osteoinductive composition comprising osteoinductive factors recovered from mineralized bone and a carrier |
06/17/2014 | CA2619989C Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria |
06/17/2014 | CA2601936C Epidermal growth factor receptor mutations |
06/17/2014 | CA2546665C Protein from horn fly saliva that disrupts hemostasis |
06/17/2014 | CA2533479C Peptide protein translation inhibitor and the use thereof for protein translation control |
06/17/2014 | CA2509840C Generation of plants with altered oil content comprising altered expression of a hio102 nucleic acid |
06/17/2014 | CA2472937C Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
06/17/2014 | CA2468178C Method for producing l-amino acid using bacteria belonging to the genus escherichia |
06/17/2014 | CA2456979C Yield-related polynucleotides and polypeptides in plants |
06/17/2014 | CA2370306C Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
06/17/2014 | CA2366062C Human dickkopf-related protein and nucleic acid molecules and uses therefor |
06/17/2014 | CA1341638C Fibroblast growth factor |
06/13/2014 | CA2799804A1 P16ink4a derived peptides for prophylaxis and therapy of hpv-associated tumors and other p16ink4a expressing tumors |
06/12/2014 | WO2014089507A1 Fgf-10 complexes |
06/12/2014 | WO2014089480A1 Treatment of inflammation, autoimmune, and neurodegenerative disorders with immunosuppressive tat derivative polypeptides |
06/12/2014 | WO2014089472A1 Peptide-albumin hydrogel properties and its applications |
06/12/2014 | WO2014089440A1 Treating oral lesions using placental extracellular matrix |
06/12/2014 | WO2014089354A1 Cd138-targeted interferon demonstrates potent apoptotic and anti-tumor activities |
06/12/2014 | WO2014089267A1 Galectin-3 fusion proteins |
06/12/2014 | WO2014089177A2 Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines |
06/12/2014 | WO2014089152A1 Hiv-1 env-binding antibodies, fusion proteins, and methods of use |
06/12/2014 | WO2014088935A2 Compositions and methods of use |
06/12/2014 | WO2014088928A1 Methods for making targeted protein toxins by sortase-mediated protein ligation |
06/12/2014 | WO2014087849A1 Adjuvant for mucous membrane vaccine |
06/12/2014 | WO2014087816A1 Method for fermenting cacao beans |
06/12/2014 | WO2014087023A1 An amphipathic peptide |
06/12/2014 | WO2014086981A1 Baculovirus system for expressing proteins forming virus-like particles |
06/12/2014 | WO2014086973A1 Enhanced production of the porcine circovirus capsid protein by a baculovirus vector expression system |
06/12/2014 | WO2014086787A1 Immunogenic composition |
06/12/2014 | WO2014086494A1 Novel recombinant clostridial neurotoxins with enhanced membrane localization |
06/12/2014 | WO2014086100A1 Heat-resistant rice gene oszfp, screening marker and separation method thereof |
06/12/2014 | WO2014085947A1 Chemokine-cytokine fusion protein and application thereof |
06/12/2014 | WO2014085861A1 A method of purifying therapeutic proteins |
06/12/2014 | WO2014062069A4 Shon as a prognostic biomarker for cancer and as a predictor of response to endocrine therapy |
06/12/2014 | WO2014060898A3 Compositions and methods relating to a mutant clostridium difficile toxin |
06/12/2014 | WO2013059493A8 Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes |
06/12/2014 | US20140165226 Antimicrobial Agents from Microbial Genomes |
06/12/2014 | US20140165223 Tnf superfamily trimerization inhibitors |
06/12/2014 | US20140165222 High affinity sumo traps |
06/12/2014 | US20140165219 MUTANT SODIUM CHANNEL Nav1.7 AND METHODS RELATED THERETO |
06/12/2014 | US20140163207 METHOD FOR PURIFYING PEGylated ERYTHROPOIETIN |
06/12/2014 | US20140163205 Designer collagens and use thereof |
06/12/2014 | US20140163204 Derivatives of growth hormone and related proteins |
06/12/2014 | US20140163201 Multispecific peptides |
06/12/2014 | US20140163101 Caprylate viral deactivation |
06/12/2014 | US20140163034 Inhibitors of anandamide transport and their therapeutic uses |
06/12/2014 | US20140162961 Compositions and methods for transport across the blood brain barrier |
06/12/2014 | US20140162956 Polypeptides |
06/12/2014 | US20140162952 Erap1-derived peptide and use thereof |
06/12/2014 | US20140162951 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
06/12/2014 | US20140162949 Treatment with human growth hormone analogues |
06/12/2014 | US20140162945 Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof |
06/12/2014 | US20140162943 N-terminus conformationally constrained glp-1 receptor agonist compounds |
06/12/2014 | US20140162938 Peptide compounds and methods of production and use thereof |
06/12/2014 | US20140162907 Method of producing a set of mhc molecules |
06/12/2014 | US20140162358 Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors |
06/12/2014 | US20140162341 Method and composition for crystallizing a gpcr |
06/12/2014 | US20140162340 Synthetic hepatitis c genome and methods of making and use |
06/12/2014 | US20140162331 Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof |
06/12/2014 | US20140162306 Polymutant tau protein variants and their use for recapitulating human tauopathies |
06/12/2014 | US20140162296 Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses Thereof |
06/12/2014 | US20140162295 Method and Biomarker for Detecting of Acute Kidney Injury |
06/12/2014 | US20140162293 Gene coded for a mhc class i molecule, plasmid, expression system protein, multimer, reagent and kit to analyze a t cell frequency |
06/12/2014 | US20140162290 Probe for detecting dead cell |
06/12/2014 | US20140161875 Antibodies to phosphorylated tau aggregates |
06/12/2014 | US20140161833 Novel neutralizing immunogen (nimiv) of rhinovirus and its uses for vaccine applications |
06/12/2014 | US20140161807 Methods of promoting cns neuronal repair by inhibiting lrp-1 |
06/12/2014 | US20140161803 Constitutively active upar variants and their use for the generation and isolation of inhibitory antibodies |
06/12/2014 | US20140161788 Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof |
06/12/2014 | US20140161767 Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using same |
06/12/2014 | US20140161765 Derivatisation of granulocyte colony-stimulating factor |
06/12/2014 | DE102010025935B4 Kollagen Collagen |
06/11/2014 | EP2741085A1 Method for detecting pancreatic cancer |
06/11/2014 | EP2740792A1 Novel modified protein comprising tandem-type multimer of mutant extracellular domain of protein g |
06/11/2014 | EP2740744A2 SP35 antibodies and uses thereof |
06/11/2014 | EP2740742A1 Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
06/11/2014 | EP2740741A1 Wnt family-derived peptide and uses thereof |
06/11/2014 | EP2740740A1 Edar ligand-derived peptide and uses thereof |
06/11/2014 | EP2740739A1 Agrocybe aegerita lectin aal-2, and encoding gene thereof, preparation method therefor and application thereof |
06/11/2014 | EP2740489A1 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
06/11/2014 | EP2740463A1 Uses of membrane vesicles of a marine organism for the industrial use thereof and method for obtaining same |
06/11/2014 | EP2740351A1 Gene and method for increasing disease resistance in perennial plants |
06/11/2014 | EP2739741A1 Organelle targeting nanocarriers |
06/11/2014 | EP2739730A2 Cell free translation system for compound screening and related uses |
06/11/2014 | EP2739725A1 Method for purifying virus-like particles (vlp) |
06/11/2014 | EP2739724A1 Recombinant swine influenza virus and uses thereof |
06/11/2014 | EP2739649A1 P97 fragments with transfer activity |
06/11/2014 | EP2739648A1 Mutations in the epidermal growth factor receptor gene |
06/11/2014 | EP2739647A1 Process for preparing human relaxin-2 |
06/11/2014 | EP2739646A1 Comprehensive buffer system for renaturing human proinsulin or proinsulin derivatives |
06/11/2014 | EP2739645A1 Treatment of heart failure and related conditions |
06/11/2014 | EP2739644A1 Proteins with pro-apoptotic and antitelomerase activity on cancer cells, their preparation and use |
06/11/2014 | EP2739643A1 Use of fmn-binding fluorescence proteins (fbfp) as new types of secretion markers |
06/11/2014 | EP2739642A1 Method for removing a lytic enzyme from a heterogeneous mixture |
06/11/2014 | EP2739641A1 Systems and methods to increase protein yield from recombinant manufacturing processes |
06/11/2014 | EP2739308A1 Hypoallergenic variants of mal d 1, the major allergen from malus domestica |
06/11/2014 | EP2739307A1 Vlps containing ligands and methods related thereto |
06/11/2014 | EP2739302A2 Novel sequences for the control of reproduction in fish |